{"document": {"publication": "Tag My News", "full_text": "an experimental drug for the liver-damaging hepatitis c virus offers an advance over the current decade-old treatment that cures only a minority of patients, maker merck &amp; co told a u.s. advisory panel on wednesday.", "title": "merck pitches hepatitis c drug to u.s. fda panel", "line_count": 1, "filename": "6571", "publication_date": "27-04-2011 17:08:20", "lines_and_colors": [["an experimental drug for the liver-damaging hepatitis c virus offers an advance over the current decade-old treatment that cures only a minority of patients, maker merck &amp; co told a u.s. advisory panel on wednesday.", {}]]}}